Literature DB >> 10066455

Cloning of a GADD34-like gene that interacts with the zinc-finger transcription factor which binds to the p21(WAF) promoter.

T Hasegawa1, H Xiao, K Isobe.   

Abstract

A histone deacetylase inhibitor has been shown to induce differentiation of many cancer cells and senescence-like state of human fibroblasts. Previously, our data suggested that the region responsive to trichostatin A (TSA), a specific inhibitor of histone deacetylase, treatment in the p21(WAF1) promoter is located -100 bp upstream from transcription initiation site and contains a GC-box where both Sp1 and Sp3 are responsible. Here we show that another zinc-finger transcription factor, BFCOL1, which binds to the proximal proalpha2(I) collagen promoter, could also bind to this GC-box of the p21 promoter. In addition, we cloned a gene whose product interacts with this factor by yeast two-hybrid method. The cloned gene was a variant of GADD34 and lacking one PEST region. We found that this cDNA product decreased the DNA binding activity of BFCOL1 to the GC-rich region of p21 minimal promoter. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10066455     DOI: 10.1006/bbrc.1999.0275

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  ZBP-89 promotes growth arrest through stabilization of p53.

Authors:  L Bai; J L Merchant
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  C-terminal region of GADD34 regulates eIF2α dephosphorylation and cell proliferation in CHO-K1 cells.

Authors:  Ryo Otsuka; Nagakatsu Harada; Shouhei Aoki; Kanna Shirai; Kazuchika Nishitsuji; Ayane Nozaki; Adzumi Hatakeyama; Masayuki Shono; Noriko Mizusawa; Katsuhiko Yoshimoto; Yutaka Nakaya; Hiroshi Kitahata; Hiroshi Sakaue
Journal:  Cell Stress Chaperones       Date:  2015-08-30       Impact factor: 3.667

3.  Interaction between DNA-damage protein GADD34 and a new member of the Hsp40 family of heat shock proteins that is induced by a DNA-damaging reagent.

Authors:  T Hasegawa; H Xiao; F Hamajima; K Isobe
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

Review 4.  Regulation of epithelial cell growth by ZBP-89: potential relevance in pancreatic cancer.

Authors:  Longchuan Bai; Craig Logsdon; Juanita L Merchant
Journal:  Int J Gastrointest Cancer       Date:  2002

5.  Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1.

Authors:  J H Connor; D C Weiser; S Li; J M Hallenbeck; S Shenolikar
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

6.  Over-expression of the transcription factor, ZBP-89, leads to enhancement of the C2C12 myogenic program.

Authors:  Morgan Salmon; Gary K Owens; Zendra E Zehner
Journal:  Biochim Biophys Acta       Date:  2009-02-14

7.  mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK.

Authors:  Devanand Sarkar; Zao-Zhong Su; Irina V Lebedeva; Moira Sauane; Rahul V Gopalkrishnan; Kristoffer Valerie; Paul Dent; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-11       Impact factor: 11.205

8.  The transcriptional repressor ZBP-89 and the lack of Sp1/Sp3, c-Jun and Stat3 are important for the down-regulation of the vimentin gene during C2C12 myogenesis.

Authors:  Morgan Salmon; Zendra E Zehner
Journal:  Differentiation       Date:  2009-02-23       Impact factor: 3.880

9.  Characterization of a functional ZBP-89 binding site that mediates Gata1 gene expression during hematopoietic development.

Authors:  Kinuko Ohneda; Shin'ya Ohmori; Yasushi Ishijima; Mayu Nakano; Masayuki Yamamoto
Journal:  J Biol Chem       Date:  2009-09-01       Impact factor: 5.157

10.  Negative regulation of GADD34 on myofibroblasts during cutaneous wound healing.

Authors:  Lintao Liu; Naomi Nishio; Sachiko Ito; Yuriko Tanaka; Ken-ichi Isobe
Journal:  Biomed Res Int       Date:  2014-08-19       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.